Skip to main content
MEDIKIT CO.,LTD logo

MEDIKIT CO.,LTD — Investor Relations & Filings

Ticker · 7749 ISIN · JP3921060004 T Manufacturing
Open in API
Filings indexed 65 across all filing types
Latest filing 2024-06-27 Regulatory Filings
Country JP Japan
Listing T 7749

About MEDIKIT CO.,LTD

http://medikit.co.jp/english/

MEDIKIT CO., LTD. is a medical device company that develops, manufactures, and sells medical equipment, with a primary focus on vascular access devices. The company's main product lines include intravenous (IV) safety catheters and hemodialysis (HD) catheters, particularly those utilizing fluorine resin. Its portfolio also encompasses artificial dialysis equipment and related components. MEDIKIT's product development philosophy emphasizes minimal invasiveness, user safety for healthcare professionals, and patient comfort during medical procedures.

Recent filings

Filing Released Lang Actions
確認書
Regulatory Filings Classification · 100% confidence The document is titled '確認書' (Confirmation Letter) and is submitted under Article 24-4-2 of the Financial Instruments and Exchange Act. It serves as an officer certification confirming the accuracy of the company's Annual Securities Report (有価証券報告書). According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations should be classified as Regulatory Filings (RNS), even if they reference a specific report type. FY 2024
2024-06-27 Japanese
有価証券報告書－第41期(2023/04/01－2024/03/31)
Annual Report Classification · 100% confidence The document is a Japanese '有価証券報告書' (Yuuka Shouken Houkokusho), which is the standard Japanese equivalent of an Annual Report (10-K). It includes a cover page with the fiscal year (第41期, 2023-04-01 to 2024-03-31), the filing date, and detailed financial tables (consolidated management indicators). It is a comprehensive annual financial disclosure document, not an announcement or a summary. FY 2024
2024-06-27 Japanese
確認書
Report Publication Announcement Classification · 100% confidence The document text contains the header "第３四半期報告書" (Third Quarter Report) and specifies a reporting period ("第41期第３四半期（自2023年10月１日 至2023年12月31日）"). It also references the Financial Instruments and Exchange Act ("金融商品取引法") and confirms the appropriateness of the filing's content by the CEO. This structure strongly indicates a comprehensive quarterly financial report, which aligns with the definition of an Interim / Quarterly Report (IR). Although it is a confirmation document related to the report, the core subject matter is the quarterly report itself, making IR the most appropriate classification over a simple RPA or RNS, especially given the explicit mention of the financial period and the nature of the content (confirmation of accuracy for the Q3 report). The document length is very short (558 chars), but the content is a formal confirmation *of* the Q3 report's accuracy, not just an announcement that a report is available. Therefore, it is classified as the report type it pertains to.
2024-02-13 Japanese
四半期報告書－第41期第3四半期(2023/10/01－2023/12/31)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for the third quarter of the fiscal year 2024, filed by Medikit Co., Ltd. with the Kanto Local Finance Bureau. It contains detailed financial statements, including the consolidated balance sheet, income statement, and comprehensive income statement, as well as notes to the financial statements. This aligns perfectly with the definition of an Interim/Quarterly Report (IR). 9M 2024
2024-02-13 Japanese
公開買付報告書
M&A Activity Classification · 100% confidence The document is explicitly titled "公開買付報告書" (Tender Offer Report) in the header and within the table structure. It details the terms of a tender offer, including the tender offer period ("公開買付期間"), the results of the offer ("買付け等の結果"), the number of shares sought and acquired, and references the relevant Japanese regulations (金融商品取引法施行令 and 内閣府令). This clearly identifies it as a filing related to a takeover bid or tender offer, which corresponds to the M&A Activity category (TAR).
2024-01-10 Japanese
公開買付届出書
M&A Activity Classification · 100% confidence The document is titled "公開買付届出書" (Tender Offer Registration Statement) and is submitted to the "関東財務局長" (Director of the Kanto Local Finance Bureau). The content details the intention to acquire the company's own shares (自己株式の取得) via a tender offer (公開買付け) targeting a specific major shareholder (ナカジマコーポレーション) and offering the opportunity to other shareholders. This structure, involving a formal filing to a regulatory body regarding a public offer to buy shares, strongly indicates a filing related to a takeover bid or a major transaction affecting share capital, which aligns best with the category for M&A Activity (TAR) or potentially Capital/Financing Update (CAP) or Share Issue/Capital Change (SHA). However, a tender offer for self-acquisition (self-tender offer) is a specific type of transaction often grouped with M&A or significant capital restructuring. Given the explicit focus on a public tender offer (公開買付届出書) to acquire shares, the most precise classification among the provided options is 'Transaction in Own Shares' (POS) or 'M&A Activity' (TAR). Since this is a self-tender offer (buyback), POS is highly relevant. However, the structure and regulatory context (Tender Offer Registration Statement) are very similar to takeover filings. Reviewing the definitions: TAR is for 'merger proposals or takeover bids'. POS is for 'Report of the company buying back or selling its own shares (share repurchase/issuance)'. Since the document explicitly details the process and terms of a self-tender offer (share repurchase), POS is the most accurate fit for the core action described, even though it's initiated by the company itself rather than an external bidder.
2023-12-06 Japanese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.